ストックスクリーナーアプリを入手
5.09
0.79%
0.04
アフターアワーズ：
4.95
-0.14
-2.75%
Immix Biopharma Inc (IMMX) 最新ニュース
Why Immix Biopharma Inc. stock remains undervalued2025 Earnings Impact & High Return Trade Guides - ulpravda.ru
Why Immix Biopharma Inc. stock is a must watch in 2025July 2025 Decliners & High Accuracy Investment Entry Signals - ulpravda.ru
What momentum indicators show for Immix Biopharma Inc. stockRate Hike & Accurate Intraday Trading Signals - ulpravda.ru
Why analysts upgrade Immix Biopharma Inc. stock2025 Market Sentiment & Technical Pattern Based Signals - ulpravda.ru
Fed Watch: Why analysts upgrade Immix Biopharma Inc stockWeekly Trading Summary & Risk Adjusted Swing Trade Ideas - moha.gov.vn
Swing Trade: Can Immix Biopharma Inc stock surprise with earnings upsidePortfolio Update Report & Consistent Profit Alerts - moha.gov.vn
Why Immix Biopharma Inc stock remains undervaluedJuly 2025 Patterns & Fast Exit and Entry Trade Guides - moha.gov.vn
Immix Biopharma, Inc. (NASDAQ:IMMX) Short Interest Up 27.5% in December - MarketBeat
Immix Biopharma (NASDAQ:IMMX) & Athira Pharma (NASDAQ:ATHA) Critical Survey - Defense World
Immix Biopharma (IMMX) price target increased by 50.00% to 12.24 - MSN
Is Immix Biopharma Inc. stock positioned well for digital economyLong Setup & Fast Exit and Entry Strategy Plans - Улправда
Immix Biopharma (IMMX) Price Target Increased by 50.00% to 12.24 - Nasdaq
Is Immix Biopharma Inc. stock resilient to inflation2025 Growth vs Value & Accurate Buy Signal Notifications - Улправда
Why Immix Biopharma Inc. stock remains on buy listsPortfolio Return Report & Precise Swing Trade Entry Alerts - DonanımHaber
Is Immix Biopharma Inc. stock positioned for long term growth2025 Retail Activity & Free Risk Controlled Daily Trade Plans - DonanımHaber
What hedge fund activity signals for Immix Biopharma Inc. stock2025 Sector Review & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Immix Biopharma (NASDAQ:IMMX) Stock Rating Upgraded by Wall Street Zen - Defense World
Immix Biopharma Inc Stock Analysis and ForecastGeopolitical Risk Analysis & Minimal Risk High Reward - earlytimes.in
Trendlines Converge — Decision Point for Tirupati Starch and Chemicals LimitedTake Profit Strategies & Compound Your Gains With Quality Stocks - earlytimes.in
Immix Biopharma FY2025 EPS Forecast Boosted by HC Wainwright - Defense World
Aug Summary: Will Immix Biopharma Inc stock benefit from infrastructure spending2025 Macro Impact & Verified Entry Point Detection - moha.gov.vn
FY2025 EPS Estimates for Immix Biopharma Lifted by Analyst - MarketBeat
Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX) - Seeking Alpha
Immix Biopharma Stock Surges 70%, With A 6-Day Winning Spree - Trefis
Immix Biopharma CFO Gabriel Morris buys $5k in shares By Investing.com - Investing.com Canada
Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares By Investing.com - Investing.com Canada
Immix Biopharma CFO Gabriel Morris buys $5k in shares - Investing.com
Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares - Investing.com
Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright - Investing.com Australia
Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright By Investing.com - Investing.com South Africa
IMMX Analyst Rating Update: HC Wainwright Raises Price Target to - GuruFocus
Immix Biopharma closes $93.7 million public offering By Investing.com - Investing.com Canada
Immix Biopharma closes $93.7 million public offering - Investing.com
Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants - marketscreener.com
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - The Manila Times
Immix Biopharma, Inc. Closes $93.7 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Immix Biopharma prices $100M equity raise via common stock and warrant offering - MSN
Taking the lead: Immix Biopharma Inc (IMMX) - setenews.com
Immix Biopharma — Promising NEXICART-2 data; runway extended - Smartkarma
Immix Biopharma Enters Underwriting Agreement with Morgan Stanley - TipRanks
Form 424B5 Immix Biopharma, Inc. - StreetInsider
Immix Biopharma’s Market Dynamics Amid Economic Shifts - timothysykes.com
Immix Soars On NXC-201 Data In Relapsed/Refractory AL Amyloidosis; BLA Planned For 2026 - Nasdaq
Immix Biopharma Prices $100 Million Offering - marketscreener.com
Immix Biopharma Announces Positive Phase 2 Trial Results - TipRanks
Form FWP Immix Biopharma, Inc. Filed by: Immix Biopharma, Inc. - StreetInsider
0.80%
4.56%
大文字化:
|
ボリューム (24 時間):